Cargando…
Progesterone Resistance in Endometriosis: Current Evidence and Putative Mechanisms
Endometriosis is an estrogen-dependent disease characterized by the growth of endometrial-like tissue outside the uterus. Progestins are currently the most commonly used treatment for endometriosis because of their excellent therapeutic effects and limited side effects. However, progestins have been...
Autores principales: | Zhang, Ping, Wang, Guoyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138736/ https://www.ncbi.nlm.nih.gov/pubmed/37108154 http://dx.doi.org/10.3390/ijms24086992 |
Ejemplares similares
-
MicroRNAs in Endometriosis: Insights into Inflammation and Progesterone Resistance
por: Hon, Jing-Xian, et al.
Publicado: (2023) -
MicroRNAs and Progesterone Receptor Signaling in Endometriosis Pathophysiology
por: Nothnick, Warren B.
Publicado: (2022) -
Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis?
por: Marquardt, Ryan M., et al.
Publicado: (2019) -
Endometriosis and Medical Therapy: From Progestogens to Progesterone Resistance to GnRH Antagonists: A Review
por: Donnez, Jacques, et al.
Publicado: (2021) -
Progesterone receptor ligands for the treatment of endometriosis: the mechanisms behind therapeutic success and failure
por: Reis, Fernando M, et al.
Publicado: (2020)